食物不安全与MASLD患病率及肝脏相关死亡率的关联
该研究结合联合国国家层面食物安全数据与2021年全球疾病负担研究的MASLD数据,采用混合效应线性回归分析204个国家食物安全指标与MASLD患病率及肝脏相关死亡率的关系。结果显示2021年MASLD患病率中位数21.77%,肝脏相关死亡率中位数2.92/10万,高SDI国家食物不安全最高三分位组患病率显著高于最低三分位组(26.73% vs 18.87%,p=0.0001),低SDI国家则相反(19.45% vs 24.96%,p=0.0008)。
要点
- 2021年204国MASLD患病率中位数21.77%,北非与中东最高(41.70%),高收入国家最低(17.31%)。
- 高SDI国家食物不安全最高三分位组MASLD患病率显著高于最低三分位组(26.73% vs 18.87%,p=0.0001)。
- 低SDI国家食物不安全最高三分位组MASLD患病率显著低于最低三分位组(19.45% vs 24.96%,p=0.0008)。
核心结论
- MASLD患病率与MASLD肝脏相关死亡率存在显著地域差异,受临床人口学因素和食物不安全影响。
- 作者认为,考虑各区域社会经济现实的有针对性公共卫生策略对减轻全球MASLD负担至关重要。
研究设计与样本
- 研究结合联合国国家层面食物安全数据与2021年全球疾病负担研究的MASLD数据。
- 采用混合效应线性回归模型(纳入国家层面随机效应)评估食物安全指标与MASLD患病率及肝脏相关死亡率的关联,并按各国社会人口指数(SDI)状态分层分析。
主要发现
- 2021年204个国家MASLD患病率中位数为21.77%(14.14%-48.18%),MASLD肝脏相关死亡率中位数为2.92/10万(0.42-10.79)。
- MASLD患病率最高位于北非与中东(41.70%),最低位于高收入国家(17.31%)。
- 调整年龄、性别和SDI后,较高的MASLD患病率与肥胖率、2型糖尿病率和低体力活动率升高相关(p<0.001)。
- 高SDI国家中,食物不安全最高三分位组MASLD患病率显著高于最低三分位组(均值26.73% vs 18.87%,p=0.0001)。
- 低SDI国家中则相反,食物不安全最高三分位组MASLD患病率显著低于最低三分位组(19.45% vs 24.96%,p=0.0008)。
临床怎么用
- 作者认为,高SDI国家公共卫生政策应关注改善食品质量、减少不健康食品消费和提升医疗可及性。
- 作者认为,低SDI国家政策应同时处理贫困相关问题并改善诊断手段和医疗基础设施可及性,以更准确估计MASLD病例。
- 作者认为,高SDI和低SDI国家均需促进体力活动以管理MASLD相关代谢状况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) is growing. This study explores the association of food insecurity with MASLD prevalence and liver-related mortality (LRM) across the globe. METHODS: The study combines United Nations' country-level food security data with the MASLD data from the Global Burden of Disease study 2021. Mixed-effects linear regression models, accounting for country-level random effects, were used to assess associations of food security indicators with MASLD prevalence and LRM. The analyses were performed according to each country's socio-demographic index (SDI) status. RESULTS: In 2021, the median MASLD prevalence and liver-related mortality (MASLD-LRM) across 204 countries was 21.77% (14.14%-48.18%) and 2.92 per 100,000 (0.42-10.79) with the highest MASLD prevalence located in North Africa & Middle East (41.70%) and the lowest prevalence in high-income countries (17.31%). After adjustments for age, gender and SDI, higher MASLD prevalence was associated with increasing rates of obesity, type 2 diabetes and low physical activity (p <0.001). When analyses were performed based on SDI status, divergent patterns of MASLD prevalence were observed. In high SDI countries (socioeconomically more developed), MASLD prevalence was significantly higher in those in the top tertile of food insecurity compared to the bottom tertile (mean, 26.73% vs. 18.87%, p = 0.0001). In contrast, in low SDI countries (socioeconomically less developed), the opposite was true (19.45% vs. 24.96%, p = 0.0008). MASLD-LRM was associated with older age, obesity, and metabolic risks (p <0.001). CONCLUSIONS: MASLD prevalence and MASLD-LRM exhibit significant geographical variability, which is influenced by clinicodemographic factors, and food insecurity. Targeted public health strategies which consider the socio-economic realities of each region are essential for mitigating the global burden of MASLD. IMPACT AND IMPLICATIONS: Metabolic dysfunction-associated steatotic liver disease (MASLD) burden varies by region, influenced by food insecurity and healthcare access. In high socio-demographic index (SDI) countries, higher MASLD prevalence is linked to the consumption of low-quality, ultra-processed foods. Public health policies should focus on improving food quality, reducing unhealthy food consumption, and enhancing healthcare access. Conversely, in low SDI countries, while food insecurity can lead to outright deficiencies, the observed lower MASLD prevalence may also be partly attributable to underdiagnosis. In this context, limited healthcare access may have contributed to underestimation of the prevalence of MASLD. Therefore, country-specific policies should address both the issues related to poverty, as well as improving access to diagnostic modalities and healthcare infrastructure to ensure more accurate estimates of cases of MASLD in the specific country. Promoting physical activity is crucial in both high and low SDI countries to manage metabolic conditions associated with MASLD.
引用
- Younossi ZM, Zelber-Sagi S, Kuglemas C, et al. Association of food insecurity with MASLD prevalence and liver-related mortality. J Hepatol. 2024. PMID: 39208992. doi:10.1016/j.jhep.2024.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。